The International Patient Summary is a truly international asset to support the safe and efficient provision of care across the globe. Read about the initiatives and experiences across a wide variety of countries.
New Zealand is actively implementing IPS
With great engagement from HL7 New Zealand, the country is moving quickly forward to implement the Patient Health Summary, based...
Read More
Canada completed a second PS-CA Projectathon
The March 2023 Projectathon was dedicated to supporting Patient Summary implementation projects across Canada. The expansion of patient summary adoption...
Read More
Battling HIV in Haiti with the IPS
One of the key challenges in the Haiti HIV program is a highly transient patient population that struggles with continuity...
Read More
Canadian IPS Projectathon
Canada organised its first IPS Projectathon in March. A Projectathon is an important step and a best-practice approach in testing...
Read More
G7 Countries promote IPS
The G7 countries have published an International Patient Summary roadmap (G7-IPS). It supports the commitment of the G7 countries to...
Read More
NHS England demonstrates the IPS
The National Health Service (NHS) in England has produced a demonstration of proof-of-concept International Patient Summary functionality, referred to as IPS....
Read More
Argentina advances in the implementation of the IPS
Promoted by the National Ministry of Health, the IPS adoption strategy by the provinces is in its final stage. Through...
Read More
Advancing the International Patient Summary in New Zealand
The International Patient Summary (IPS) is endorsed by the Health Information Standards Organisation (HISO) in Aotearoa New Zealand as a...
Read More
Patient Summary adoption in The Netherlands
The Health Care Information Council in The Netherlands adopted the Patient Summary (BgZ) and the use of Clinical Information Models...
Read More
The Value of the International Patient Summary in Canada
The International Patient Summary—what is it, how are other countries using it, and is it valuable for Canadians? The answers to...
Read More